Nuclear factor-?B, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity
Open Access
- 16 October 2002
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 102 (5) , 476-482
- https://doi.org/10.1002/ijc.10745
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53Journal of Biological Chemistry, 2002
- Comparison of Doxorubicin- and MEN 10755-Induced Long-Term Progressive Cardiotoxicity in the RatJournal of Cardiovascular Pharmacology, 2000
- DNA damage activates p53 through a phosphorylation–acetylation cascadeGenes & Development, 1998
- Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.JNCI Journal of the National Cancer Institute, 1997
- A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisonsTrends in Pharmacological Sciences, 1997
- Activation of NF-κB by Antineoplastic AgentsJournal of Biological Chemistry, 1997
- Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cellsNucleic Acids Research, 1996
- DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.Molecular and Cellular Biology, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992